These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 23428789)

  • 1. C-reactive protein levels in schizophrenia: a review and meta-analysis.
    Miller BJ; Culpepper N; Rapaport MH
    Clin Schizophr Relat Psychoses; 2014 Jan; 7(4):223-30. PubMed ID: 23428789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein alterations in bipolar disorder: a meta-analysis.
    Dargél AA; Godin O; Kapczinski F; Kupfer DJ; Leboyer M
    J Clin Psychiatry; 2015 Feb; 76(2):142-50. PubMed ID: 25742201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-Reactive Protein: Higher During Acute Psychotic Episodes and Related to Cortical Thickness in Schizophrenia and Healthy Controls.
    Jacomb I; Stanton C; Vasudevan R; Powell H; O'Donnell M; Lenroot R; Bruggemann J; Balzan R; Galletly C; Liu D; Weickert CS; Weickert TW
    Front Immunol; 2018; 9():2230. PubMed ID: 30364161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High C-reactive protein levels are associated with depressive symptoms in schizophrenia.
    Faugere M; Micoulaud-Franchi JA; Faget-Agius C; Lançon C; Cermolacce M; Richieri R
    J Affect Disord; 2018 Jan; 225():671-675. PubMed ID: 28917193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein and metabolic syndrome in patients with bipolar disorder compared to patients with schizophrenia.
    Vuksan-Cusa B; Sagud M; Jakovljević M
    Psychiatr Danub; 2010 Jun; 22(2):275-7. PubMed ID: 20562761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein-C Reactive as Biomarker Predictor of Schizophrenia Phases of Illness? A Systematic Review.
    Orsolini L; Sarchione F; Vellante F; Fornaro M; Matarazzo I; Martinotti G; Valchera A; Di Nicola M; Carano A; Di Giannantonio M; Perna G; Olivieri L; De Berardis D
    Curr Neuropharmacol; 2018; 16(5):583-606. PubMed ID: 29357805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated C-reactive protein levels in schizophrenia inpatients is associated with aggressive behavior.
    Barzilay R; Lobel T; Krivoy A; Shlosberg D; Weizman A; Katz N
    Eur Psychiatry; 2016 Jan; 31():8-12. PubMed ID: 26657596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein serum level in drug-free male Egyptian patients with schizophrenia.
    Fawzi MH; Fawzi MM; Fawzi MM; Said NS
    Psychiatry Res; 2011 Nov; 190(1):91-7. PubMed ID: 21621854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis and modelling of cholesterol and high-density lipoprotein cholesterol changes across the range of C-reactive protein levels in clinical practice as an aid to better understanding of inflammation-lipid interactions.
    Johnsson H; Panarelli M; Cameron A; Sattar N
    Ann Rheum Dis; 2014 Aug; 73(8):1495-9. PubMed ID: 23716069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination Survey.
    Miller M; Zhan M; Havas S
    Arch Intern Med; 2005 Oct; 165(18):2063-8. PubMed ID: 16216995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Waist circumference adds to the variance in plasma C-reactive protein levels in elderly patients with metabolic syndrome.
    Dupuy AM; Jaussent I; Lacroux A; Durant R; Cristol JP; Delcourt C
    Gerontology; 2007; 53(6):329-39. PubMed ID: 17551260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases.
    Li JJ; Fang CH
    Med Hypotheses; 2004; 62(4):499-506. PubMed ID: 15050096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein. Should it be considered a coronary risk factor?
    Aronow WS
    Geriatrics; 2003 May; 58(5):19-22, 25. PubMed ID: 12756677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of C-reactive protein in schizophrenia: an overview.
    Singh B; Chaudhuri TK
    Psychiatry Res; 2014 May; 216(2):277-85. PubMed ID: 24565000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels.
    Osimo EF; Baxter LJ; Lewis G; Jones PB; Khandaker GM
    Psychol Med; 2019 Sep; 49(12):1958-1970. PubMed ID: 31258105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between C-reactive protein and body mass index in patients with polycystic ovarian syndrome.
    Moradi S; Mollabashi M; Kerman SR
    Gynecol Endocrinol; 2011 Jul; 27(7):480-5. PubMed ID: 20836727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A significant causal association between C-reactive protein levels and schizophrenia.
    Inoshita M; Numata S; Tajima A; Kinoshita M; Umehara H; Nakataki M; Ikeda M; Maruyama S; Yamamori H; Kanazawa T; Shimodera S; Hashimoto R; Imoto I; Yoneda H; Iwata N; Ohmori T
    Sci Rep; 2016 May; 6():26105. PubMed ID: 27193331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic, quantitative review of blood autoantibodies in schizophrenia.
    Ezeoke A; Mellor A; Buckley P; Miller B
    Schizophr Res; 2013 Oct; 150(1):245-51. PubMed ID: 23953827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between high sensitivity C-reactive protein and metabolic syndrome in subjects completing the National Health and Nutrition Examination Survey (NHANES) 2009-10.
    Voils SA; Cooper-DeHoff RM
    Diabetes Metab Syndr; 2014; 8(2):88-90. PubMed ID: 24907172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory cardiovascular risk markers in women with hypopituitarism.
    Sesmilo G; Miller KK; Hayden D; Klibanski A
    J Clin Endocrinol Metab; 2001 Dec; 86(12):5774-81. PubMed ID: 11739438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.